02/21/2025 5:33 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
02/20/2025 3:53 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
02/20/2025 3:55 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
02/05/2025 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
02/05/2025 3:39 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
02/03/2025 7:36 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 3:31 PM | Kazia Therapeutics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
01/30/2025 6:57 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025 7:02 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/30/2025 7:05 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/16/2025 9:40 AM | Alumni Capital LP (Filed by) Kazia Therapeutics (Subject)
| Form SCHEDULE 13G | |
Get the Latest News and Ratings for KZIA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kazia Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
01/13/2025 7:00 AM | Kazia Therapeutics (Filer)
| Form 424B5 | |
01/13/2025 7:03 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 7:05 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/13/2025 7:07 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/10/2025 7:00 AM | Kazia Therapeutics (Filer)
| Form 424B5 | |
12/31/2024 7:46 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/31/2024 7:49 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/31/2024 7:43 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024 8:01 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/11/2024 8:04 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/11/2024 7:58 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024 3:33 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/03/2024 3:38 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/02/2024 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
12/02/2024 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
11/27/2024 3:30 PM | Kazia Therapeutics (Filer)
| Form POS AM | |
11/27/2024 3:30 PM | Kazia Therapeutics (Filer)
| Form POS AM | |
11/06/2024 6:53 PM | Kazia Therapeutics (Subject) PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
| Form SC 13G | |
11/01/2024 3:05 PM | Kazia Therapeutics (Filer)
| Form NT 20-F | |
10/24/2024 7:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024 7:33 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024 7:38 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024 7:22 AM | Kazia Therapeutics (Filer)
| Form 6-K/A | |
10/15/2024 6:01 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 6:03 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/15/2024 6:04 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/15/2024 6:06 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024 3:52 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024 3:55 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024 3:57 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad) Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000.
Should you sit on the sideline while this is happening? That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y |
09/23/2024 8:27 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024 8:23 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 8:25 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024 8:26 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024 8:06 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024 8:10 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024 8:12 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024 8:14 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/12/2024 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
09/04/2024 7:56 PM | Kazia Therapeutics (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
08/12/2024 6:28 PM | Alumni Capital LP (Filed by) Kazia Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2024 8:26 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024 8:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024 8:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024 8:19 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2024 4:29 PM | Alumni Capital LP (Filed by) Kazia Therapeutics (Subject)
| Form SC 13G | |
06/28/2024 3:27 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
06/24/2024 7:14 PM | Kazia Therapeutics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
06/04/2024 11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
05/29/2024 7:55 AM | Kazia Therapeutics (Filer)
| Form F-1 Registration statement for securities of certain foreign private issuers | |
05/23/2024 6:00 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024 6:03 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
05/01/2024 3:01 PM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/01/2024 3:06 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
04/19/2024 3:26 PM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024 3:30 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/27/2024 7:37 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/27/2024 7:26 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024 7:02 AM | Kazia Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |